Alcon Inc. (ALC)Healthcare | Medical Instruments & Supplies | Geneva, Switzerland | NYSE
81.32 USD
+1.77
(2.225%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 80.86 -0.46 (-0.460%) ⇩ (April 17, 2026, 8 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★★★☆ | Dividends: ★★★☆☆ |
Hot Take | April 19, 2026, 12:15 a.m. EDT
Alcon (ALC) represents a classic 'Broken Merger' buy scenario where the failed LENSAR acquisition left a pure-play, high-quality cash cow at a valuation discount. While the short-term model predicts a slight downward drift (-1%) due to lack of immediate catalysts, the medium-term macro tailwinds in the eye-care sector and massive institutional buy-backs ($750M) outweigh the failed merger drag. The market is undervaluing the 'tail' of the ophthalmic device franchise. Long-term hold with a view on organic growth and M&A hunting rather than short-term volatility trading. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.039699 |
| AutoARIMA | 0.039721 |
| AutoTheta | 0.040266 |
| MSTL | 0.040509 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 6.62 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.479 |
| Excess Kurtosis | -0.84 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2026-05-05 |
| Last Dividend Date | 2025-05-12 |
| Debt to Equity Ratio | 23.808 |
| Revenue per Share | 21.089 |
| Market Cap | 40,646,189,056 |
| Trailing P/E | 41.07 |
| Forward P/E | 20.69 |
| Beta | 0.74 |
| Profit Margins | 9.42% |
| Website | https://www.alcon.com |
As of April 19, 2026, 12:15 a.m. EDT: Options flow indicates a significant bullish bias from expiration 2026-06-18 onwards, particularly in 2027 Leaps where OTM call Open Interest at $85.00 and $90.00 strikes far exceeds Put OI. However, near-term expirations (April 2026 and June 2026) show a 'bearish delta bleed' with high OTM Put OI ($70 strike level up to $1.5k OI in Dec 2026) compared to Call OI. Yields are near zero, suggesting speculation is focused on capital appreciation rather than premium collection.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 0.35% | 0.35% | 0.32% | — |
| Date | Dividend | Yield % |
|---|---|---|
| 2025-05-13 | 0.331 | 0.354960 |
| 2024-05-14 | 0.264 | 0.296735 |
| 2023-05-10 | 0.236 | 0.294646 |
| 2022-05-03 | 0.205 | 0.291783 |
| 2021-05-04 | 0.110 | 0.149500 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.11008972 |
| Address1 | Chemin de Blandonnet 8 |
| Address2 | Vernier |
| All Time High | 101.1 |
| All Time Low | 39.37 |
| Ask | 81.22 |
| Ask Size | 800 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 1,344,950 |
| Average Daily Volume3 Month | 1,654,169 |
| Average Volume | 1,654,169 |
| Average Volume10Days | 1,344,950 |
| Beta | 0.737 |
| Bid | 81.42 |
| Bid Size | 700 |
| Board Risk | 3 |
| Book Value | 45.205 |
| City | Geneva |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | Switzerland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 81.32 |
| Current Ratio | 2.115 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 82.365 |
| Day Low | 81.15 |
| Debt To Equity | 23.808 |
| Display Name | Alcon |
| Dividend Date | 1,747,267,200 |
| Dividend Rate | 0.35 |
| Dividend Yield | 0.43 |
| Earnings Call Timestamp End | 1,778,068,800 |
| Earnings Call Timestamp Start | 1,778,068,800 |
| Earnings Growth | -0.222 |
| Earnings Quarterly Growth | -0.236 |
| Earnings Timestamp | 1,778,011,200 |
| Earnings Timestamp End | 1,778,011,200 |
| Earnings Timestamp Start | 1,778,011,200 |
| Ebitda | 2,331,000,064 |
| Ebitda Margins | 0.22410999 |
| Enterprise To Ebitda | 18.564 |
| Enterprise To Revenue | 4.16 |
| Enterprise Value | 43,272,638,464 |
| Eps Current Year | 3.4392 |
| Eps Forward | 3.93072 |
| Eps Trailing Twelve Months | 1.98 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,778,025,600 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 79.161 |
| Fifty Day Average Change | 2.1589966 |
| Fifty Day Average Change Percent | 0.027273487 |
| Fifty Two Week Change Percent | -11.008972 |
| Fifty Two Week High | 99.2 |
| Fifty Two Week High Change | -17.879997 |
| Fifty Two Week High Change Percent | -0.18024191 |
| Fifty Two Week Low | 71.55 |
| Fifty Two Week Low Change | 9.769997 |
| Fifty Two Week Low Change Percent | 0.13654782 |
| Fifty Two Week Range | 71.55 - 99.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,554,816,600,000 |
| Float Shares | 486,267,842 |
| Forward Eps | 3.93072 |
| Forward P E | 20.688322 |
| Free Cashflow | 1,233,750,016 |
| Full Exchange Name | NYSE |
| Full Time Employees | 25,942 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.55667996 |
| Gross Profits | 5,790,000,128 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00185 |
| Held Percent Institutions | 0.67768997 |
| Implied Shares Outstanding | 499,830,169 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,747,094,400 |
| Last Dividend Value | 0.331 |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. |
| Long Name | Alcon Inc. |
| Market | us_market |
| Market Cap | 40,646,189,056 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_694234 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 980,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 39,761,791,743 |
| Number Of Analyst Opinions | 16 |
| Open | 81.56 |
| Operating Cashflow | 2,271,000,064 |
| Operating Margins | 0.117 |
| Overall Risk | 4 |
| Payout Ratio | 0.172 |
| Peg Ratio | 1.82 |
| Phone | 41 589 112 110 |
| Post Market Change | -0.45999908 |
| Post Market Change Percent | -0.56566536 |
| Post Market Price | 80.86 |
| Post Market Time | 1,776,470,400 |
| Previous Close | 79.55 |
| Price Eps Current Year | 23.645035 |
| Price Hint | 2 |
| Price To Book | 1.798916 |
| Price To Sales Trailing12 Months | 3.9079115 |
| Profit Margins | 0.09422 |
| Quick Ratio | 1.281 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.62963 |
| Region | US |
| Regular Market Change | 1.77 |
| Regular Market Change Percent | 2.22501 |
| Regular Market Day High | 82.365 |
| Regular Market Day Low | 81.15 |
| Regular Market Day Range | 81.15 - 82.365 |
| Regular Market Open | 81.56 |
| Regular Market Previous Close | 79.55 |
| Regular Market Price | 81.32 |
| Regular Market Time | 1,776,456,002 |
| Regular Market Volume | 1,309,408 |
| Return On Assets | 0.025729999 |
| Return On Equity | 0.044970002 |
| Revenue Growth | 0.086 |
| Revenue Per Share | 21.089 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 487,427,920 |
| Shares Percent Shares Out | 0.01 |
| Shares Short | 4,820,959 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 5,297,253 |
| Short Name | Alcon Inc. |
| Short Ratio | 3.29 |
| Source Interval | 15 |
| Symbol | ALC |
| Target High Price | 113.0 |
| Target Low Price | 75.0 |
| Target Mean Price | 94.68312 |
| Target Median Price | 96.0 |
| Total Cash | 1,612,000,000 |
| Total Cash Per Share | 3.307 |
| Total Debt | 5,246,000,128 |
| Total Revenue | 10,401,000,448 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.353 |
| Trailing Annual Dividend Yield | 0.0044374606 |
| Trailing Eps | 1.98 |
| Trailing P E | 41.070705 |
| Trailing Peg Ratio | 1.8167 |
| Triggerable | 1 |
| Two Hundred Day Average | 79.90065 |
| Two Hundred Day Average Change | 1.4193497 |
| Two Hundred Day Average Change Percent | 0.017763931 |
| Type Disp | Equity |
| Volume | 1,309,408 |
| Website | https://www.alcon.com |
| Zip | 1,214 |